ATE404661T1 - Transdifferenzierung von pankreas- acinuszellen - Google Patents

Transdifferenzierung von pankreas- acinuszellen

Info

Publication number
ATE404661T1
ATE404661T1 AT03700250T AT03700250T ATE404661T1 AT E404661 T1 ATE404661 T1 AT E404661T1 AT 03700250 T AT03700250 T AT 03700250T AT 03700250 T AT03700250 T AT 03700250T AT E404661 T1 ATE404661 T1 AT E404661T1
Authority
AT
Austria
Prior art keywords
transdifferentiation
pancreas
acinus
cells
acinus cells
Prior art date
Application number
AT03700250T
Other languages
English (en)
Inventor
Lawrence Rosenberg
Original Assignee
Univ Mcgill
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Mcgill filed Critical Univ Mcgill
Application granted granted Critical
Publication of ATE404661T1 publication Critical patent/ATE404661T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0676—Pancreatic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/998—Proteins not provided for elsewhere

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
AT03700250T 2002-01-11 2003-01-10 Transdifferenzierung von pankreas- acinuszellen ATE404661T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US34689002P 2002-01-11 2002-01-11

Publications (1)

Publication Number Publication Date
ATE404661T1 true ATE404661T1 (de) 2008-08-15

Family

ID=23361448

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03700250T ATE404661T1 (de) 2002-01-11 2003-01-10 Transdifferenzierung von pankreas- acinuszellen

Country Status (20)

Country Link
US (1) US7662768B2 (de)
EP (1) EP1463801B1 (de)
JP (1) JP2005514426A (de)
KR (1) KR20040072680A (de)
CN (1) CN1610693A (de)
AR (1) AR038281A1 (de)
AT (1) ATE404661T1 (de)
AU (1) AU2003201553A1 (de)
BR (1) BR0306656A (de)
CA (1) CA2469052A1 (de)
DE (1) DE60322831D1 (de)
IL (1) IL162749A0 (de)
MA (1) MA27413A1 (de)
MX (1) MXPA04006385A (de)
NO (1) NO20042205L (de)
PE (1) PE20030744A1 (de)
PL (1) PL371260A1 (de)
RU (1) RU2004119417A (de)
TW (1) TW200302228A (de)
WO (1) WO2003057862A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060009516A1 (en) * 2002-10-24 2006-01-12 Mcgill University Use of ingap for reversing diabetes
US20160039877A1 (en) 2013-03-15 2016-02-11 Shenzhen Hightide Biopharmaceutical, Ltd. Compositions and methods of using islet neogenesis peptides and analogs thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5834590A (en) * 1995-02-22 1998-11-10 Eastern Virginia Medical School Of The Medical College Of Hampton Roads Ingap protein involved in pancreatic islet neogenesis
EP0815129B1 (de) 1995-02-22 2011-01-05 Eastern Virginia Medical School of the Medical College of Hampton Roads Ingap-protein und dessen beteiligung an der neogenese pankreatischer inselzellen
WO2003033697A1 (en) * 2001-10-18 2003-04-24 Ixion Biotechnology, Inc. Conversion of liver stem and progenitor cells to pancreatic functional cells

Also Published As

Publication number Publication date
JP2005514426A (ja) 2005-05-19
US7662768B2 (en) 2010-02-16
TW200302228A (en) 2003-08-01
IL162749A0 (en) 2005-11-20
WO2003057862A2 (en) 2003-07-17
US20030203850A1 (en) 2003-10-30
NO20042205L (no) 2004-09-13
WO2003057862A3 (en) 2003-10-02
EP1463801A2 (de) 2004-10-06
BR0306656A (pt) 2004-10-05
CA2469052A1 (en) 2003-07-17
AR038281A1 (es) 2005-01-12
MXPA04006385A (es) 2004-10-04
RU2004119417A (ru) 2005-02-27
EP1463801B1 (de) 2008-08-13
AU2003201553A1 (en) 2003-07-24
DE60322831D1 (de) 2008-09-25
CN1610693A (zh) 2005-04-27
KR20040072680A (ko) 2004-08-18
MA27413A1 (fr) 2005-07-01
PE20030744A1 (es) 2003-10-24
PL371260A1 (en) 2005-06-13

Similar Documents

Publication Publication Date Title
DK1487805T3 (da) Pyrimidinderivater
NO20023283D0 (no) Flammestopper
DK1620437T3 (da) 5,7-diaminopyrazolo-4,3-d-pyrimidiner, der er anvendelige til behandling af hypertension
DE50311534D1 (de) Gewebeband-einrichtung
DE60318920D1 (de) Induktion von Insulin-produzierende Zellen
DE60139175D1 (de) Entzerrer von Strahlungsleistungen
ATE510556T1 (de) Verwendung von erythropoietin
DE50212455D1 (de) Verwendung von Dimerdiolen
DE50313510D1 (de) Zellkultureinsatz
IS7833A (is) Efnasambönd með sameinaða heteróhringi
DE502004011575D1 (de) Verwendung von Dioldimerfettsäureestern
DK1519928T3 (da) Fremgangsmåde til fremstilling af heterocykliske fluoralkenylsulfoner
DE112004001132D2 (de) Regelung von Brennstoffzellen
DE60318819D1 (de) Hitzestabile mutanten von stärkebiosyntheseenzymen
DE50307817D1 (de) Wellenleiter in porösen substraten
DE502004008433D1 (de) Wägezelle
NO20043664L (no) Ny fremgangsmate
IS7943A (is) Ný amínóbensófenónefnasambönd
ATE404661T1 (de) Transdifferenzierung von pankreas- acinuszellen
DE60327426D1 (de) Markierung von substraten
DE60216986D1 (de) Neue verwendung von pipatalin
DK1675601T4 (da) Moderering af virkningen af enterotoksiner
DE502004006136D1 (de) Verrastung von Baugruppen
SE0202741D0 (sv) Scrubber
FIU20020058U0 (fi) Rakenne-elementti

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties